BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2551803)

  • 1. Phospholipase C-mediated intestinal mucosal damage is ameliorated by quinacrine.
    Otamiri T
    Food Chem Toxicol; 1989 Jun; 27(6):399-402. PubMed ID: 2551803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinacrine prevention of intestinal ischaemic mucosal damage is partly mediated through inhibition of intraluminal phospholipase A2.
    Otamiri T
    Agents Actions; 1988 Dec; 25(3-4):378-84. PubMed ID: 3218612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase A2 inhibition prevents mucosal damage associated with small intestinal ischaemia in rats.
    Otamiri T; Lindahl M; Tagesson C
    Gut; 1988 Apr; 29(4):489-94. PubMed ID: 2836275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased phospholipase A2 and decreased lysophospholipase activity in the small intestinal mucosa after ischaemia and revascularisation.
    Otamiri T; Franzén L; Lindmark D; Tagesson C
    Gut; 1987 Nov; 28(11):1445-53. PubMed ID: 3428670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of phospholipase A2 and oxygenated free radicals in mucosal damage after small intestinal ischemia and reperfusion.
    Otamiri T; Tagesson C
    Am J Surg; 1989 Jun; 157(6):562-5; discussion 566. PubMed ID: 2543228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of surface-active food additives on the integrity and permeability of rat intestinal mucosa.
    Tagesson C; Edling C
    Food Chem Toxicol; 1984 Nov; 22(11):861-4. PubMed ID: 6094320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of quinacrine on plasma malondialdehyde after small intestinal ischemia and reperfusion.
    Otamiri TA
    Circ Shock; 1988; 24(1):63-9. PubMed ID: 2830996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen radicals, lipid peroxidation, and neutrophil infiltration after small-intestinal ischemia and reperfusion.
    Otamiri T
    Surgery; 1989 May; 105(5):593-7. PubMed ID: 2539652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium and phospholipase A2 appear to be involved in the pathogenesis of hemorrhagic shock-induced mucosal injury and bacterial translocation.
    Xu D; Lu Q; Deitch EA
    Crit Care Med; 1995 Jan; 23(1):125-31. PubMed ID: 8001364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginkgo biloba extract prevents mucosal damage associated with small-intestinal ischaemia.
    Otamiri T; Tagesson C
    Scand J Gastroenterol; 1989 Aug; 24(6):666-70. PubMed ID: 2554486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase A2 and mediation of the activation of short-circuit current in the rat colonic mucosa.
    Diener M; Rummel W
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):652-8. PubMed ID: 1944607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of putative phospholipase A2 inhibitors on acetic acid-induced acute colitis in the rat.
    Fabia R; Ar'Rajab A; Willén R; Andersson R; Bengmark S
    Br J Surg; 1993 Sep; 80(9):1199-204. PubMed ID: 8402133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lipid peroxidation in muscle homogenates by phospholipase A2 inhibitors.
    Jackson MJ; Jones DA; Harris EJ
    Biosci Rep; 1984 Jul; 4(7):581-7. PubMed ID: 6478056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phospholipase A2 inhibitor quinacrine prevents increased immunoreactivity to cytoplasmic phospholipase A2 (cPLA2) and hydroxynonenal (HNE) in neurons of the lateral septum following fimbria-fornix transection.
    Lu XR; Ong WY; Halliwell B
    Exp Brain Res; 2001 Jun; 138(4):500-8. PubMed ID: 11465749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of distinct phospholipases mediating bradykinin and noradrenaline hyperalgesia.
    Taiwo YO; Heller PH; Levine JD
    Neuroscience; 1990; 39(2):523-31. PubMed ID: 2128375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reperfusion mucosal damage after complete intestinal ischemia in the dog: the effects of antioxidant and phospholipase A2 inhibitor therapy.
    Boros M; Karácsony G; Kaszaki J; Nagy S
    Surgery; 1993 Feb; 113(2):184-91. PubMed ID: 8430367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha potentiates phospholipase A2-stimulated release and metabolism of arachidonic acid in cultured intestinal epithelial cells (INT 407).
    Gustafson-Svärd C; Tagesson C; Boll RM; Kald B
    Scand J Gastroenterol; 1993 Apr; 28(4):323-30. PubMed ID: 8488366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase C from Clostridium perfringens stimulates phospholipase A2-mediated arachidonic acid release in cultured intestinal epithelial cells (INT 407).
    Gustafson C; Tagesson C
    Scand J Gastroenterol; 1990 Apr; 25(4):363-71. PubMed ID: 2110684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic modulation of platelet phospholipase A2 activity and platelet aggregation by mepacrine (quinacrine).
    Chan AC; Pritchard ET; Gerrard JM; Man RY; Choy PC
    Biochim Biophys Acta; 1982 Oct; 713(1):170-2. PubMed ID: 7138896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between accumulation of phospholipase A2 reaction products and Ca2+ release in isolated liver mitochondria.
    Rustenbeck I; Münster W; Lenzen S
    Biochim Biophys Acta; 1996 Nov; 1304(2):129-38. PubMed ID: 8954136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.